Case ReportsDisseminated Herpes Zoster During COVID-19Voisin, Olivier MD∗; Deluca, Nina MD∗; Mahé, Annabelle MD∗; Lelorc'h, Erwan MD∗; Hubert, Sidonie MD∗; Ménage, Elodie MD∗; Borie, Marie-Françoise MD∗; Azria, Philippe MD∗; Fite, Charlotte MD†; Pilmis, Benoit MD‡; Mourad, Jean-Jacques MD, PhD∗Author Information From the ∗Department of Internal Medicine †Department of Dermatology ‡Department of Infectious Disease, Groupe Hospitalier Paris Saint-Joseph, Paris, France. Correspondence to: Voisin Olivier, MD, Department of Internal Medicine Groupe Hospitalier Paris Saint-Joseph, 185 rue Raymond Losserand 75014 Paris, France. E-mail: [email protected]. The authors have no funding or conflicts of interest to disclose. Infectious Diseases in Clinical Practice: March 2021 - Volume 29 - Issue 2 - p e109-e110 doi: 10.1097/IPC.0000000000000971 Buy Metrics Abstract During the SARS-CoV-2 pandemic, a variety of dermatological conditions were reported by physicians. Given the context, these lesions have been labeled as secondary to SARS-CoV-2 infection. We report the case of a recurrence of herpes zoster in a patient hospitalized with an SARS-CoV-2 infection. The rash occurred on the 15th day of hospitalization while the patient was recovering from a severe form. Local swab showed the presence of varicella-zoster virus within the vesicles. Dermatological symptoms secondary to COVID-19 have been frequently described. This is the first case that demonstrates the recurrence of herpes zoster during a SARS-CoV-2 infection. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.